Brufen Export Market Intelligence: India's 140 Suppliers Shipping to 78 Countries — TransData Nexus 2026

Q: Who are the top brufen exporters from India?

The top brufen exporters from India are: 1. MYLAN LABORATORIES LIMITED — $2.5M (55.0% market share); 2. GELTEC PRIVATE LIMITED — $994.9K (22.2% market share); 3. ABBOTT INDIA LIMITED — $414.4K (9.2% market share); 4. MEDREICH LIMITED — $206.3K (4.6% market share); 5. RIZOCHEM PHARMACEUTICALS — $147.6K (3.3% market share). Together they account for 94.3% of India's total brufen export value.

Q: What is the total export value of brufen from India?

The total export value of brufen from India is $4.5M USD, recorded across 1,838 shipment transactions from 140 active exporters to 78 destination countries. The average shipment value is $2.4K.

Q: Which countries import brufen from India?

India exports brufen to 78 countries worldwide. The top importing countries are: NETHERLANDS (77.1% share, $3.5M), SRI LANKA (7.5% share, $336.3K), QATAR (3.3% share, $148.1K), PORTUGAL (2.6% share, $115.1K), MALDIVES (1.7% share, $77.1K). These five markets account for 92.2% of total export value.

Q: What is the HS code for brufen exports from India?

The primary HS code for brufen exports from India is 30049063. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of brufen exports from India?

The average unit price for brufen exports from India is $1.85 USD per unit, with prices ranging from $0.01 to $95.05 depending on formulation, packaging, and order volume. The total market is valued at $4.5M across 1,838 shipments.

Q: Which ports handle brufen exports from India?

The primary ports for brufen exports from India are SAHAR AIR CARGO ACC (INBOM4) (23.0% of shipments), SAHAR AIR (19.9% of shipments), DELHI AIR CARGO ACC (INDEL4) (10.3% of shipments), Bombay Air (5.8% of shipments), DELHI AIR (5.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of brufen?

India is one of the world's leading exporters of brufen due to its large base of 140 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports brufen to 78 countries, demonstrating 40% global market coverage.

Q: What certifications do Indian brufen exporters need?

Indian brufen exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import brufen from India?

There are 447 registered buyers importing brufen from India, spread across 78 countries. The repeat buyer rate is 51.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top brufen supplier from India?

MYLAN LABORATORIES LIMITED is the leading brufen exporter from India with a market share of 55.0% and total export value of $2.5M across 35 shipments. The top 5 suppliers together control 94.3% of total export value.

Suresh Sormare

Brufen

India Pharmaceutical Trade Intelligence

$4.5M140 Suppliers78 CountriesHS 30049063

ExportsIndia → NETHERLANDS77.1%India → SRI LANKA7.5%

#1 Supplier: MYLAN LABORATORIES #1 Buyer: BGP PRODUCTS

Brufen Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Brufen to the World

Between 2022 and 2026, India exported $4.5M worth of brufen across 1,838 verified shipments to 78 countries — covering 40% of world markets in the Brand Names & OTC Products segment. The largest destination is NETHERLANDS (77.1%). MYLAN LABORATORIES LIMITED leads with a 55.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Brufen export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Brufen export data snapshot — $4.5M · 140 exporters · 78 countriesTransData Nexus · Indian Customs Data

Top Brufen Exporters from India

140 active exporters · Ranked by export value

View all 140 →

Top Brufen Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MYLAN LABORATORIES LIMITED	$2.5M	35	1	55.0%
2	GELTEC PRIVATE LIMITED

Top Countries Importing Brufen from India

78 destination markets · Ranked by import value

All 78 countries →

Top Countries Importing Brufen from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	NETHERLANDS	$3.5M	77.1%
2	SRI LANKA	$336.3K	7.5%
3	QATAR	$148.1K	3.3%
4	PORTUGAL	$115.1K	2.6%
5	MALDIVES	$77.1K	1.7%
6	NEPAL	$60.7K	1.4%
7	AUSTRALIA	$56.9K	1.3%
8	NEW ZEALAND	$42.8K	1.0%
9	SEYCHELLES	$34.0K	0.8%
10	GUYANA	$23.5K	0.5%

NETHERLANDS is India's largest brufen export destination, absorbing 77.1% of total exports worth $3.5M. The top 5 importing countries — NETHERLANDS, SRI LANKA, QATAR, PORTUGAL, MALDIVES — together account for 92.2% of India's total brufen export value. The remaining 73 destination countries collectively receive the other 7.8%, indicating a broadly diversified export footprint across multiple regions.

Regulatory Landscape — Brufen

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, ibuprofen is approved for over-the-counter (OTC) use and is listed in the FDA's Orange Book. The FDA has not issued any import alerts specifically targeting ibuprofen products from India as of March 2026. However, Import Alert 66-40, updated in February 2026, addresses drugs from firms that have not met Good Manufacturing Practices (GMPs), which could impact ibuprofen imports if compliance issues arise. Given the presence of 140 active Indian exporters, it is imperative for these entities to ensure strict adherence to FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union, ibuprofen is authorized for marketing by the European Medicines Agency (EMA) and is available both as a prescription and OTC medication, depending on the dosage. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) similarly regulates ibuprofen, ensuring compliance with safety and efficacy standards. Manufacturers exporting to these markets must comply with EU Good Manufacturing Practice (GMP) guidelines, which are harmonized across member states to ensure product quality and safety.

3WHO Essential Medicines & Global Standards

Ibuprofen is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in basic healthcare systems. The drug is also subject to international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, ibuprofen is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for sale. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for ibuprofen formulations to ensure affordability; the latest revision was in January 2026. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for ibuprofen have long expired, leading to a competitive generic market. This has resulted in a proliferation of manufacturers and exporters, contributing to the significant export volume from India.

6Recent Industry Developments

In March 2026, the FDA updated Import Alert 66-40, emphasizing the need for compliance with GMPs for drug imports, which could affect ibuprofen exporters. In January 2026, the NPPA revised the ceiling price for ibuprofen formulations to ensure continued affordability in the domestic market. Additionally, in February 2026, the EMA issued new guidelines on the labeling requirements for NSAIDs, including ibuprofen, to enhance patient safety and information clarity.

These developments highlight the dynamic regulatory environment affecting ibuprofen production and export, necessitating continuous monitoring and compliance by stakeholders.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Brufen

Retail & reference prices across 9 markets vs. India FOB export price of $1.85/unit

Global Price Benchmark for Brufen across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	Not available	USD	Brufen is not marketed under this brand name in the United States. Ibuprofen is available under various brand names and as a generic. The FDA Orange Book provides information on approved ibuprofen formulations.
United Kingdom	Not available	GBP	Brufen 400 mg tablets are listed in the NHS Drug Tariff. Specific pricing details can be obtained from the latest NHS Drug Tariff publications.
Germany	Not available	EUR	Germany employs a reference pricing system for pharmaceuticals. Brufen's pricing would be subject to these regulations. Specific prices can be obtained from the German Federal Joint Committee (G-BA).

Supply Chain Risk Assessment — Brufen

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China, with estimates indicating that 70–80% of APIs and KSMs are sourced from Chinese manufacturers. This dependency exposes the supply chain to risks associated with geopolitical tensions, trade restrictions, and environmental regulations in China. For instance, in 2018, the closure of approximately 145 API manufacturers in China due to stringent environmental norms led to significant supply disruptions and price escalations for Indian pharmaceutical companies.

To mitigate these risks, the Indian government introduced the Production Linked Incentive (PLI) scheme in 2020, aiming to boost domestic manufacturing of APIs and reduce reliance on imports. The scheme has led to increased investments in local API production, with commitments exceeding ₹4,570 crore by 2025. However, the full impact of these initiatives on reducing import dependency is yet to be realized.

2Supplier Concentration & Single-Source Risk

The export data reveals a high supplier concentration, with the top five exporters accounting for 94.3% of Brufen exports. MYLAN LABORATORIES LIMITED alone contributes 55.0% of the total export value. Such concentration poses a single-source risk, where disruptions at a major supplier can significantly impact the entire supply chain. While the PLI scheme aims to diversify and strengthen domestic manufacturing capabilities, its effectiveness in addressing supplier concentration remains to be seen.

Access Complete Brufen Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,838 transactions across 78 markets.

Request Demo View Pricing

Frequently Asked Questions — Brufen Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top brufen exporters from India?

The leading brufen exporters from India are MYLAN LABORATORIES LIMITED, GELTEC PRIVATE LIMITED, ABBOTT INDIA LIMITED, and 10 others. MYLAN LABORATORIES LIMITED leads with 55.0% market share ($2.5M). The top 5 suppliers together control 94.3% of total export value.

What is the total export value of brufen from India?

The total export value of brufen from India is $4.5M, recorded across 1,838 shipments from 140 active exporters to 78 countries. The average shipment value is $2.4K.

Which countries import brufen from India?

India exports brufen to 78 countries. The top importing countries are NETHERLANDS (77.1%), SRI LANKA (7.5%), QATAR (3.3%), PORTUGAL (2.6%), MALDIVES (1.7%), which together account for 92.2% of total export value.

What is the HS code for brufen exports from India?

The primary HS code for brufen exports from India is 30049063. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Brufen

Brufen

How India Exports Brufen to the World

Top Brufen Exporters from India

Top Countries Importing Brufen from India

Quick Facts

Related Brand Names & OTC Products

Related Analysis

Need Details?

Regulatory Landscape — Brufen

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Brufen

Supply Chain Risk Assessment — Brufen

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Brufen Trade Intelligence

Frequently Asked Questions — Brufen Exports from India

Who are the top brufen exporters from India?

What is the total export value of brufen from India?

Which countries import brufen from India?

What is the HS code for brufen exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of brufen exports from India?

Which ports handle brufen exports from India?

Why is India a leading exporter of brufen?

What certifications do Indian brufen exporters need?

How many buyers import brufen from India?

What is the market share of the top brufen exporter from India?

Analysis Methodology